- Global Pharma News & Resources

Transdermal Drug Delivery System Market to Record a CAGR of 4.6%, OTC and Rx to be Largest Revenue-generating Application Segment –

Pune, Maharashtra, India, September 21 2022 (Wiredrelease) Prudour Pvt. Ltd –:Transdermal Drug Delivery System Market: Introduction

The transdermal drug delivery systems market is expected to reach USD 7.2 billion by 2023 from an estimated USD 5.8 billion in 2018, at a CAGR of 4.6% during the forecast period. 

Majorly, the market is driven by the rising prevalence of chronic diseases. Traditional drug delivery systems such as oral drugs are less potent due to their hepatic first pass metabolism.

These devices have a higher drug diffusion capability than conventional routes of drug distribution, such as oral, intravenous and pulmonary. This is what accounts for their efficacy. The market growth can also be attributed to the rising desire by patients and doctors to have pain-free drug delivery. This is expected to further drive market demand during the forecast period. These factors are expected to increase the growth potential over the forecast period.

This report provides valuable information to shareholders, new entrants, frontrunners, and shareholders. It helps them formulate strategies for the future, as well as take the necessary steps to strengthen their market position. The report includes graphical representations and tabular representations to provide an in-depth analysis of every segment as well as their sub-segments. This report is intended to aid market players, investors, new entrants, and others in formulating strategies based on the fastest-growing segments and highest revenue generation. data from the latest shows that North America in 2021 will be the largest Transdermal Drug Delivery System market. Mexico, Canada and the US are experiencing nominal CAGRs of [2022-2031] above the global average.

Identify the key factors that will drive your company’s growth. Request a brochure of this report here:

 [Sample reports can be used to check out our detailed reports and study material before purchasing] 

1. The updated 150+ page reports give an in-depth analysis and commentary on the COVID-19 virus pandemic. 

2. You can find out about industry data and interviews with experts to learn more about topics like regional impact analysis, global outlook, competitive landscape analysis, market size, share, and the size of regional markets. 

3. These reports are available in PDF format. You can view them on your computer or print them. 

4. PDF sample report provides additional information on Major Market Players including their Sales Volume, Business Strategy, Revenue Analysis and Revenue Analysis. This gives readers an advantage over other people. 

5. The Research report includes a detailed analysis of key factors that influence the market’s growth. 

6. Sample report also provides insight on major market players, their business strategies, and revenue analysis to give readers an edge over others.

Transdermal Drug Delivery System Market – Competitive Landscape 

Teve (Actavis)
Johnson & Johnson
Teikoku Seiyaku
Huarun 999
Haw Par
Mentholatum Company
Laboratoires Genevrier 

Recent Developments
Hisamitsu Pharmaceutical (Japan), introduced ALLESAGA TAPE to the Japanese market in January 2018.

UCB (Belgium), received an Import Drug License from China Food and Drug Administration in July 2018 for its transdermal rotigotine pad–NEUPRO.

Luye Pharma (China), and Bayer AG (Switzerland), reached an agreement to acquire global rights for the Apleek contraceptive patch transdermal in August 2018.

Competitive Benchmarking

Competitive benchmarking allows you to see how your competitors are doing and compare it to your company’s. professionals assist our stakeholders in keeping track of competitors, identifying improvement areas, increasing profits, and designing better go-to-market strategies.

Interested in Procure The Data? Inquire here at 

Transdermal Drug Delivery System Market Segmentation

Based on the type, the Transdermal Drug Delivery System market is segmented into 


Based on the application, the Transdermal Drug Delivery System market is segmented into


Market Breakup by Region: 

– North America (United States, Canada) 

– Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others) 

– Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others) 

– Latin America (Brazil, Mexico, Others) 

– The Middle East and Africa 

Market Report Coverage and Deliverables will help you to understand:

1. Company revenue shares | revenue (US$ Mn)

2. Upcoming Regional opportunities

3. Latest trends & Market dynamics

4. Competitive benchmarking

5. Key Financial Charts

Grab the full detailed report here:

Key Questions Answered in This Report: 

Q1. What is the market size of Transdermal Drug Delivery System? 

Q2. What are the elements of retail Transdermal Drug Delivery System? 

Q3. What are the key decision drivers for service buyers? 

Q4. How can we accelerate our bidding process? 

Q5. What is the potential of the Transdermal Drug Delivery System Market? 

Q6. Who are the prominent players in Transdermal Drug Delivery System Market? 

Q7. What are the different types of Transdermal Drug Delivery System market? 

Q8. What are the top strategies that companies adopt in Transdermal Drug Delivery System Market? 

Q9. What is the future of Transdermal Drug Delivery System? 

Trending Reports (Book Now with Save 25% [Single User], 38% [Multi-User], 45% [Corporate Users] + Covid-19 scenario+ Impact of Russia-Ukraine war):

Courier, Express & Parcel Services Market [Profit Markup] | Statistics, Regional And Forecast to 2031

Freestanding Tubs Market 2022 : Technology, Future Trends and Opportunities 2031

Waterproof Watch Market Report | Global Forecast From 2022 To 2032

Brake oil Aftermarket for Off-highway vehicles Market [+Target Markets] | Share, Progress Insight 2031

Animal Protein Market Business Growing Strategies, Industry Segmentation and Forecast 2031

Get in Touch with Us :

Global Business Development Teams – (Powered By Prudour Pvt. Ltd.)

Send Email:

Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Tel: +1 718 618 4351


Read Our Innovative Blogs @

This content has been published by Prudour Pvt. Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 21-Sep-2022